Tag: monoclonal
OSE Immunotherapeutics receives first US patent grant for OSE-279, an anti-PD1 monoclonal antibody, and its use in the treatment of cancer – 03/21/2022 at 18:00
• A grant agreement issued by the United States Patent and Trademark Office • This new patent will protect OSE-279 until 2039 Nantes, France – March 21, 2022, 6:00 p.m.…
Against severe forms of Covid-19, access to dual monoclonal antibody therapies is widened
A nurse administers Dr. Prabakar Tummala an infusion of bamlanivimab, a monoclonal antibody, at Desert Valley Hospital on Thursday, December 17, 2020 in Victorville, California. IRFAN KHAN / LOS ANGELES…